Solu-Medrone is indicated to treat any condition in which rapid and intense corticosteroid effect is required such as: 1. Dermatological disease Severe erythema multiforme (Stevens-Johnson syndrome) 2. Allergic states Bronchial asthma Angioneurotic oedema Anaphylaxis 3. Gastro-intestinal diseases Ulcerative colitis Crohn's disease 4. Respiratory diseases Aspiration of gastric contents Fulminating or disseminated tuberculosis (with appropriate anti-tuberculous chemotherapy) 5. Neurological disorders Cerebral oedema secondary to cerebral tumour Acute exacerbations of multiple sclerosis superimposed on a relapsing-remitting background 6. Miscellaneous T.B. meningitis (with appropriate antituberculous chemotherapy) Transplantation
Corticosteroid (glucocorticoid). Depo-Medrone with Lidocaine is indicated in conditions requiring a glucocorticoid effect: e.g. anti-inflammatory or anti-rheumatic. It is recommended for local use where the added anaesthetic effect would be considered advantageous. Depo-Medrone with Lidocaine may be used as follows: Intra-articular administration Rheumatoid arthritis Osteo-arthritis with an inflammatory component Periarticular administration Epicondylitis Intrabursal administration Subacromial bursitis Prepatellar bursitis Olecranon bursitis Tendon sheath administration Tendinitis Tenosynovitis Epicondylitis Therapy with Depo-Medrone with Lidocaine does not obviate the need for the conventional measures usually employed. Although this method of treatment will ameliorate symptoms, it is in no sense a cure and the hormone has no effect on the cause of the inflammation.